Who is eligible for GLP-1 medications
Clinical trials show semaglutide delivers 15% weight loss vs 6% for Contrave
Physiology of Weight Regain: Lessons From the Classic Minnesota Starvation Experiment on Human Body Composition Regulation
4 Mechanisms of hepatoprotection by GLP-1RAs as immune-metabolic modulators 4.1 Immunomodulatory mechanism of hepatic injuries by GLP-1RAs GLP-1RAs reduce inflammation, downregulate pro-inflammatory cytokines, and influence immune cell differentiation via the GLP-1 receptor, which alters macrophage polarization and inhibits fibrosis ( 4.1.1 GLP1-RAs attenuate the inflammation in MASLD by downregulating multiple inflammatory factors In animal models, GLP-1RAs have shown promising results in decreasing the expression of various inflammatory markers, including TLR2 and C-X3-C chemokine receptor 1 (CX3CR1), as well as reducing the expression of genes related to liver fibrosis and fat accumulation
Keywords: GLP-1 receptor agonists, dermatological side effects, inflammatory skin diseases, hypersensitivity reactions, psoriasis, hidradenitis suppurativa, injection site reactions, immune modulation, metabolic changes, weight loss 1
This is relevant for patients or families with substance use concerns
